An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

NCT01399190 · clinicaltrials.gov ↗

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: Bevacizumab
BIOLOGICAL: Capecitabine
DRUG: Oxaliplatin

Sponsor

Hoffmann-La Roche